Chris Estes

7.9k total citations · 2 hit papers
25 papers, 2.7k citations indexed

About

Chris Estes is a scholar working on Epidemiology, Hepatology and Oncology. According to data from OpenAlex, Chris Estes has authored 25 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 21 papers in Hepatology and 2 papers in Oncology. Recurrent topics in Chris Estes's work include Hepatitis C virus research (20 papers), Liver Disease Diagnosis and Treatment (19 papers) and Hepatitis B Virus Studies (15 papers). Chris Estes is often cited by papers focused on Hepatitis C virus research (20 papers), Liver Disease Diagnosis and Treatment (19 papers) and Hepatitis B Virus Studies (15 papers). Chris Estes collaborates with scholars based in United States, Egypt and Australia. Chris Estes's co-authors include Homie Razavi, Sarah Blach, Kathryn Razavi‐Shearer, E. Gower, Ritesh Kumar, Thierry Poynard, Elamin H. Elbasha, Imam Waked, Devin Razavi‐Shearer and Ivane Gamkrelidze and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Chris Estes

24 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Global epidemiology and genotype distribution of the hepatitis C virus infection

2014 1.4k citations E. Gower, Chris Estes et al. Journal of Hepatology profile →
Chronic hepatitis C virus (HCV) disease burden and cost in the United States

2012 372 citations Homie Razavi, Elamin H. Elbasha et al. Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chris Estes United States	14	2.4k	2.3k	352	101	76	25	2.7k
Sarah Blach Switzerland	15	2.1k 0.9×	2.0k 0.9×	338 1.0×	92 0.9×	61 0.8×	43	2.3k
Mauro Viganò Italy	27	2.2k 0.9×	2.4k 1.0×	285 0.8×	88 0.9×	91 1.2×	131	2.9k
Vilma Sniukiene United States	15	2.3k 1.0×	2.0k 0.9×	510 1.4×	233 2.3×	108 1.4×	39	2.6k
Mark Danta Australia	20	1.3k 0.5×	1.2k 0.5×	460 1.3×	106 1.0×	125 1.6×	66	1.8k
Wolf Peter Hofmann Germany	24	1.8k 0.8×	1.7k 0.8×	268 0.8×	107 1.1×	167 2.2×	72	2.3k
Norbert Bräu United States	24	1.9k 0.8×	1.6k 0.7×	617 1.8×	76 0.8×	34 0.4×	68	2.2k
Mariantonietta Pisaturo Italy	26	1.3k 0.5×	1.4k 0.6×	257 0.7×	72 0.7×	137 1.8×	102	1.8k
Kathryn Razavi‐Shearer United States	7	1.5k 0.6×	1.4k 0.6×	207 0.6×	72 0.7×	63 0.8×	14	1.7k
Lois Larsen United States	24	2.0k 0.8×	1.8k 0.8×	612 1.7×	137 1.4×	171 2.3×	54	2.7k
Gabriella Verucchi Italy	21	1.5k 0.6×	1.5k 0.6×	286 0.8×	104 1.0×	102 1.3×	86	2.0k

Countries citing papers authored by Chris Estes

Since Specialization

Citations

This map shows the geographic impact of Chris Estes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Estes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Estes more than expected).

Fields of papers citing papers by Chris Estes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Estes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Estes. The network helps show where Chris Estes may publish in the future.

Co-authorship network of co-authors of Chris Estes

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Estes. A scholar is included among the top collaborators of Chris Estes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Estes. Chris Estes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Estes, Chris, et al.. (2025). Value of Stool-Based Colorectal Cancer Screening: Integrating Real-World Adherence, Detection, and Prevention in a Cohort-Based Modeling Analysis. Journal of Clinical Medicine. 15(1). 41–41.

Alagöz, Oğuzhan, Folasade P. May, Chyke A. Doubeni, et al.. (2024). Impact of racial disparities in follow-up and quality of colonoscopy on colorectal cancer outcomes. JNCI Journal of the National Cancer Institute. 116(11). 1807–1816. 4 indexed citations

Musabaev, Erkin, Chris Estes, Shakhlo Sadirova, et al.. (2023). Viral hepatitis elimination challenges in low‐ and middle‐income countries—Uzbekistan Hepatitis Elimination Program (UHEP). Liver International. 43(4). 773–784. 10 indexed citations

Blach, Sarah, Devin Razavi‐Shearer, Ellen Mooneyhan, et al.. (2022). Evaluation of global progress towards HBV and HCV elimination. Journal of Hepatology. 77. S230–S231. 4 indexed citations

Dugan, Ellen, Sarah Blach, Mia J. Biondi, et al.. (2021). Global prevalence of hepatitis C virus in women of childbearing age in 2019: a modelling study. The Lancet. Gastroenterology & hepatology. 6(3). 169–184. 39 indexed citations

Blach, Sarah, Loreta A. Kondili, Alessio Aghemo, et al.. (2020). Impact of COVID-19 on global HCV elimination efforts. Journal of Hepatology. 74(1). 31–36. 184 indexed citations

Schmelzer, Jonathan, Ellen Dugan, Sarah Blach, et al.. (2020). Global prevalence of hepatitis C virus in children in 2018: a modelling study. The Lancet. Gastroenterology & hepatology. 5(4). 374–392. 79 indexed citations

Alswat, Khalid, Abdulrahman Aljumah, Faisal M. Sanai, et al.. (2018). Nonalcoholic fatty liver disease burden – Saudi Arabia and United Arab Emirates, 2017–2030. Saudi Journal of Gastroenterology. 24(4). 211–219. 98 indexed citations

Gountas, Ilias, Ivane Gamkrelidze, Sarah Blach, et al.. (2017). HCV elimination among people who inject drugs. What would happen after the WHO HCV elimination target is achieved?. Journal of Hepatology. 66(1). S405–S406. 1 indexed citations

10.

Dore, Gregory J., Jason Grebely, Behzad Hajarizadeh, et al.. (2017). O12 Australia could meet the WHO HCV elimination targets if the current rollout of DAA treatment is continued. Journal of Virus Eradication. 3. 5–5. 2 indexed citations

11.

Ridruejo, Ezequiel, Fernando Bessone, Jorge Daruich, et al.. (2016). Hepatitis C virus infection in Argentina: Burden of chronic disease. World Journal of Hepatology. 8(15). 649–649. 5 indexed citations

12.

Hajarizadeh, Behzad, Jason Grebely, Hamish McManus, et al.. (2016). Chronic hepatitis C burden and care cascade in Australia in the era of interferon‐based treatment. Journal of Gastroenterology and Hepatology. 32(1). 229–236. 51 indexed citations

13.

Estes, Chris, Wael Abdel‐Razek, Eman Abdelsameea, et al.. (2015). Economic burden of hepatitis C in Egypt: the future impact of highly effective therapies. Alimentary Pharmacology & Therapeutics. 42(6). 696–706. 64 indexed citations

14.

Ferreira, Paulo Roberto Abrão, Carlos Eduardo Brandão‐Mello, Chris Estes, et al.. (2015). Disease burden of chronic hepatitis C in Brazil. The Brazilian Journal of Infectious Diseases. 19(4). 363–368. 13 indexed citations

15.

Gower, E., Chris Estes, Sarah Blach, Kathryn Razavi‐Shearer, & Homie Razavi. (2014). Global epidemiology and genotype distribution of the hepatitis C virus infection. Journal of Hepatology. 61(1). S45–S57. 1402 indexed citations breakdown →

16.

Waked, Imam, Manal H. El‐Sayed, Chris Estes, et al.. (2014). The current and future disease burden of chronic hepatitis C virus infection in Egypt. Arab Journal of Gastroenterology. 15(2). 45–52. 86 indexed citations

17.

Sievert, William, Homie Razavi, Chris Estes, et al.. (2014). Enhanced antiviral treatment efficacy and uptake in preventing the rising burden of hepatitis C‐related liver disease and costs in Australia. Journal of Gastroenterology and Hepatology. 29(S1). 1–9. 57 indexed citations

18.

Hamoudi, Waseem, et al.. (2013). HCV infection prevalence in a population recruited at health centers in Jordan. SHILAP Revista de lepidopterología. 3(2). 67–67. 10 indexed citations

19.

Razavi, Homie, et al.. (2013). 51 HCV TREATMENT RATE IN SELECT EUROPEAN COUNTRIES IN 2004–2010. Journal of Hepatology. 58. S22–S23. 11 indexed citations

20.

Razavi, Homie, et al.. (2012). Chronic hepatitis C virus (HCV) disease burden and cost in the United States. Hepatology. 57(6). 2164–2170. 372 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact